{"transactions":[{"id":2647630,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2021-07-01T21:43:55.000Z","date":"2021-06-30","kind":"sale","acquired":false,"shares":25000,"price":165,"value":4125000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":573007,"source":{"system":"sec-edgar","filing":"0001209191-21-044516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121044516/doc4.xml","form_type":"4"}},{"id":2650072,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2021-06-30T21:33:29.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":25000,"price":156.55,"value":3913750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":598007,"source":{"system":"sec-edgar","filing":"0001209191-21-044012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121044012/doc4.xml","form_type":"4"}},{"id":2657151,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2021-06-23T21:54:30.000Z","date":"2021-06-21","kind":"sale","acquired":false,"shares":50,"price":130.27,"value":6513.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":623007,"source":{"system":"sec-edgar","filing":"0001209191-21-042811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121042811/doc4.xml","form_type":"4"}},{"id":2657150,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2021-06-23T21:54:30.000Z","date":"2021-06-21","kind":"sale","acquired":false,"shares":7299,"price":129.46,"value":944928.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.20 to $130.11, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":623057,"source":{"system":"sec-edgar","filing":"0001209191-21-042811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121042811/doc4.xml","form_type":"4"}},{"id":2657149,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2021-06-23T21:54:30.000Z","date":"2021-06-21","kind":"sale","acquired":false,"shares":12630,"price":128.76,"value":1626238.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.195 to $129.195, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":630356,"source":{"system":"sec-edgar","filing":"0001209191-21-042811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121042811/doc4.xml","form_type":"4"}},{"id":2657148,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2021-06-23T21:54:30.000Z","date":"2021-06-21","kind":"sale","acquired":false,"shares":2969,"price":127.71,"value":379170.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.19 to $128.19, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":642986,"source":{"system":"sec-edgar","filing":"0001209191-21-042811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121042811/doc4.xml","form_type":"4"}},{"id":2657147,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2021-06-23T21:54:30.000Z","date":"2021-06-21","kind":"sale","acquired":false,"shares":881,"price":126.62,"value":111552.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.175 to $127.175, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":645955,"source":{"system":"sec-edgar","filing":"0001209191-21-042811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121042811/doc4.xml","form_type":"4"}},{"id":2657146,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2021-06-23T21:54:30.000Z","date":"2021-06-21","kind":"sale","acquired":false,"shares":1171,"price":125.58,"value":147054.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.095 to $126.08, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":646836,"source":{"system":"sec-edgar","filing":"0001209191-21-042811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121042811/doc4.xml","form_type":"4"}},{"id":2960863,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-02T21:26:08.000Z","date":"2020-11-30","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 15, 2017 with respect to 270,000 Common Shares and originally vested in 48 equal monthly installments commencing upon the grant date. Pursuant to Dr. Novak's amended and restated employment agreement with the Company, subject to his continued employment, beginning November 30, 2018, the remaining unvested options from this grant vest in equal monthly installments at the rate of 50% of the amounts originally scheduled to vest on any one vesting date, and the original vesting schedule was extended to reflect the amended schedule."}],"balance_after":140315,"derivative":{"exercise_price":14.43,"expiration_date":"2027-06-15","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-20-061162","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120061162/doc4.xml","form_type":"4"}},{"id":2960862,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-02T21:26:08.000Z","date":"2020-11-30","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on October 18, 2016 with respect to 200,000 Common Shares and originally vested in 48 equal monthly installments beginning October 31, 2016. Pursuant to Dr. Novak's amended and restated employment agreement with the Company, subject to his continued employment, beginning November 30, 2018, the remaining unvested options from this grant vest in equal monthly installments at the rate of 50% of the amounts originally scheduled to vest on any one vesting date, and the original vesting schedule was extended to reflect the amended schedule."}],"balance_after":61893,"derivative":{"exercise_price":14,"expiration_date":"2026-10-18","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-20-061162","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120061162/doc4.xml","form_type":"4"}},{"id":2960861,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-12-02T21:26:08.000Z","date":"2020-11-30","kind":"sale","acquired":false,"shares":50000,"price":125,"value":6250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":648007,"source":{"system":"sec-edgar","filing":"0001209191-20-061162","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120061162/doc4.xml","form_type":"4"}},{"id":2960860,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-12-02T21:26:08.000Z","date":"2020-11-30","kind":"exercise","acquired":true,"shares":50000,"price":14.43,"value":721500.0,"ownership":{"direct":true},"balance_after":698007,"source":{"system":"sec-edgar","filing":"0001209191-20-061162","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120061162/doc4.xml","form_type":"4"}},{"id":2960859,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-12-02T21:26:08.000Z","date":"2020-11-30","kind":"sale","acquired":false,"shares":50000,"price":125,"value":6250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":648007,"source":{"system":"sec-edgar","filing":"0001209191-20-061162","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120061162/doc4.xml","form_type":"4"}},{"id":2960858,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-12-02T21:26:08.000Z","date":"2020-11-30","kind":"exercise","acquired":true,"shares":50000,"price":14,"value":700000.0,"ownership":{"direct":true},"balance_after":698007,"source":{"system":"sec-edgar","filing":"0001209191-20-061162","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120061162/doc4.xml","form_type":"4"}},{"id":3008312,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-13T20:44:23.000Z","date":"2020-10-09","kind":"exercise","acquired":false,"shares":2762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 15, 2017 with respect to 270,000 Common Shares and originally vested in 48 equal monthly installments commencing upon the grant date. Pursuant to Dr. Novak's amended and restated employment agreement with the Company, subject to his continued employment, beginning November 30, 2018, the remaining unvested options from this grant vest in equal monthly installments at the rate of 50% of the amounts originally scheduled to vest on any one vesting date, and the original vesting schedule was extended to reflect the amended schedule."}],"balance_after":190315,"derivative":{"exercise_price":14.43,"expiration_date":"2027-06-15","underlying":"Common Shares","underlying_shares":2762},"source":{"system":"sec-edgar","filing":"0001209191-20-054650","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120054650/doc4.xml","form_type":"4"}},{"id":3008311,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-13T20:44:23.000Z","date":"2020-10-08","kind":"exercise","acquired":false,"shares":22238,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 15, 2017 with respect to 270,000 Common Shares and originally vested in 48 equal monthly installments commencing upon the grant date. Pursuant to Dr. Novak's amended and restated employment agreement with the Company, subject to his continued employment, beginning November 30, 2018, the remaining unvested options from this grant vest in equal monthly installments at the rate of 50% of the amounts originally scheduled to vest on any one vesting date, and the original vesting schedule was extended to reflect the amended schedule."}],"balance_after":193077,"derivative":{"exercise_price":14.43,"expiration_date":"2027-06-15","underlying":"Common Shares","underlying_shares":22238},"source":{"system":"sec-edgar","filing":"0001209191-20-054650","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120054650/doc4.xml","form_type":"4"}},{"id":3008310,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-10-13T20:44:23.000Z","date":"2020-10-09","kind":"sale","acquired":false,"shares":2762,"price":100,"value":276200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":648007,"source":{"system":"sec-edgar","filing":"0001209191-20-054650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120054650/doc4.xml","form_type":"4"}},{"id":3008309,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-10-13T20:44:23.000Z","date":"2020-10-09","kind":"exercise","acquired":true,"shares":2762,"price":14.43,"value":39855.66,"ownership":{"direct":true},"balance_after":650769,"source":{"system":"sec-edgar","filing":"0001209191-20-054650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120054650/doc4.xml","form_type":"4"}},{"id":3008308,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-10-13T20:44:23.000Z","date":"2020-10-08","kind":"sale","acquired":false,"shares":22238,"price":100,"value":2223800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":648007,"source":{"system":"sec-edgar","filing":"0001209191-20-054650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120054650/doc4.xml","form_type":"4"}},{"id":3008307,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-10-13T20:44:23.000Z","date":"2020-10-08","kind":"exercise","acquired":true,"shares":22238,"price":14.43,"value":320894.34,"ownership":{"direct":true},"balance_after":670245,"source":{"system":"sec-edgar","filing":"0001209191-20-054650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120054650/doc4.xml","form_type":"4"}},{"id":3039355,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-03T20:44:37.000Z","date":"2020-09-01","kind":"exercise","acquired":false,"shares":21067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on June 15, 2017 with respect to 270,000 Common Shares and originally vested in 48 equal monthly installments commencing upon the grant date. Pursuant to Dr. Novak's amended and restated employment agreement with the Company, subject to his continued employment, beginning November 30, 2018, the remaining unvested options from this grant vest in equal monthly installments at the rate of 50% of the amounts originally scheduled to vest on any one vesting date, and the original vesting schedule was extended to reflect the amended schedule."}],"balance_after":215315,"derivative":{"exercise_price":14.43,"expiration_date":"2027-06-15","underlying":"Common Shares","underlying_shares":21067},"source":{"system":"sec-edgar","filing":"0001209191-20-049425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120049425/doc4.xml","form_type":"4"}},{"id":3039354,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-03T20:44:37.000Z","date":"2020-09-01","kind":"exercise","acquired":false,"shares":3933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on October 18, 2016 with respect to 200,000 Common Shares and originally vested in 48 equal monthly installments beginning October 31, 2016. Pursuant to Dr. Novak's amended and restated employment agreement with the Company, subject to his continued employment, beginning November 30, 2018, the remaining unvested options from this grant vest in equal monthly installments at the rate of 50% of the amounts originally scheduled to vest on any one vesting date, and the original vesting schedule was extended to reflect the amended schedule."}],"balance_after":111893,"derivative":{"exercise_price":14,"expiration_date":"2026-10-18","underlying":"Common Shares","underlying_shares":3933},"source":{"system":"sec-edgar","filing":"0001209191-20-049425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120049425/doc4.xml","form_type":"4"}},{"id":3039353,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-09-03T20:44:37.000Z","date":"2020-09-01","kind":"sale","acquired":false,"shares":3840,"price":93.19,"value":357849.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.005 to $93.81, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":648007,"source":{"system":"sec-edgar","filing":"0001209191-20-049425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120049425/doc4.xml","form_type":"4"}},{"id":3039352,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-09-03T20:44:37.000Z","date":"2020-09-01","kind":"sale","acquired":false,"shares":19754,"price":92.59,"value":1829022.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.99 to $92.965, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":651847,"source":{"system":"sec-edgar","filing":"0001209191-20-049425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120049425/doc4.xml","form_type":"4"}},{"id":3039351,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-09-03T20:44:37.000Z","date":"2020-09-01","kind":"sale","acquired":false,"shares":1406,"price":91.54,"value":128705.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.93 to $91.805, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":671601,"source":{"system":"sec-edgar","filing":"0001209191-20-049425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120049425/doc4.xml","form_type":"4"}},{"id":3039350,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-09-03T20:44:37.000Z","date":"2020-09-01","kind":"exercise","acquired":true,"shares":21067,"price":14.43,"value":303996.81,"ownership":{"direct":true},"balance_after":673007,"source":{"system":"sec-edgar","filing":"0001209191-20-049425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120049425/doc4.xml","form_type":"4"}},{"id":3039349,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-09-03T20:44:37.000Z","date":"2020-09-01","kind":"exercise","acquired":true,"shares":3933,"price":14,"value":55062.0,"ownership":{"direct":true},"balance_after":651940,"source":{"system":"sec-edgar","filing":"0001209191-20-049425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120049425/doc4.xml","form_type":"4"}},{"id":3049959,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-21T20:11:39.000Z","date":"2020-08-19","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on October 18, 2016 with respect to 200,000 Common Shares and originally vested in 48 equal monthly installments beginning October 31, 2016. Pursuant to Dr. Novak's amended and restated employment agreement with the Company, subject to his continued employment, beginning November 30, 2018, the remaining unvested options from this grant vest in equal monthly installments at the rate of 50% of the amounts originally scheduled to vest on any one vesting date, and the original vesting schedule was extended to reflect the amended schedule."}],"balance_after":115826,"derivative":{"exercise_price":14,"expiration_date":"2026-10-18","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-047908","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120047908/doc4.xml","form_type":"4"}},{"id":3049958,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-08-21T20:11:39.000Z","date":"2020-08-19","kind":"sale","acquired":false,"shares":25000,"price":100,"value":2500000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":648007,"source":{"system":"sec-edgar","filing":"0001209191-20-047908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120047908/doc4.xml","form_type":"4"}},{"id":3049957,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-08-21T20:11:39.000Z","date":"2020-08-19","kind":"exercise","acquired":true,"shares":25000,"price":14,"value":350000.0,"ownership":{"direct":true},"balance_after":673007,"source":{"system":"sec-edgar","filing":"0001209191-20-047908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120047908/doc4.xml","form_type":"4"}},{"id":3085644,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-09T20:00:30.000Z","date":"2020-07-07","kind":"exercise","acquired":false,"shares":19414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on October 18, 2016 with respect to 200,000 Common Shares and originally vested in 48 equal monthly installments beginning October 31, 2016. Pursuant to Dr. Novak's amended and restated employment agreement with the Company, subject to his continued employment, beginning November 30, 2018, the remaining unvested options from this grant vest in equal monthly installments at the rate of 50% of the amounts originally scheduled to vest on any one vesting date, and the original vesting schedule was extended to reflect the amended schedule."}],"balance_after":140826,"derivative":{"exercise_price":14,"expiration_date":"2026-10-18","underlying":"Common Shares","underlying_shares":19414},"source":{"system":"sec-edgar","filing":"0000899243-20-018812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924320018812/doc4.xml","form_type":"4"}},{"id":3085643,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-09T20:00:30.000Z","date":"2020-07-07","kind":"exercise","acquired":false,"shares":5586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on September 10, 2015 with respect to 268,093 Common Shares with 94,950 shares immediately vested on the grant date and the remaining 173,143 shares vesting in 31 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.81,"expiration_date":"2025-09-10","underlying":"Common Shares","underlying_shares":5586},"source":{"system":"sec-edgar","filing":"0000899243-20-018812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924320018812/doc4.xml","form_type":"4"}},{"id":3085642,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-07-09T20:00:30.000Z","date":"2020-07-07","kind":"sale","acquired":false,"shares":25000,"price":90,"value":2250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":648007,"source":{"system":"sec-edgar","filing":"0000899243-20-018812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924320018812/doc4.xml","form_type":"4"}},{"id":3085641,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-07-09T20:00:30.000Z","date":"2020-07-07","kind":"exercise","acquired":true,"shares":19414,"price":14,"value":271796.0,"ownership":{"direct":true},"balance_after":673007,"source":{"system":"sec-edgar","filing":"0000899243-20-018812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924320018812/doc4.xml","form_type":"4"}},{"id":3085640,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-07-09T20:00:30.000Z","date":"2020-07-07","kind":"exercise","acquired":true,"shares":5586,"price":1.81,"value":10110.66,"ownership":{"direct":true},"balance_after":653593,"source":{"system":"sec-edgar","filing":"0000899243-20-018812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924320018812/doc4.xml","form_type":"4"}},{"id":3088921,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-07-06T20:14:11.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":50000,"price":80,"value":4000000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":648007,"source":{"system":"sec-edgar","filing":"0000950123-20-006683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095012320006683/doc4.xml","form_type":"4"}},{"id":3099804,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-06-25T20:28:55.000Z","date":"2020-06-23","kind":"sale","acquired":false,"shares":50000,"price":75,"value":3750000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":698007,"source":{"system":"sec-edgar","filing":"0001209191-20-038910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120038910/doc4.xml","form_type":"4"}},{"id":3133819,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-05-27T20:34:49.000Z","date":"2020-05-26","kind":"sale","acquired":false,"shares":36616,"price":70.27,"value":2573006.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":748007,"source":{"system":"sec-edgar","filing":"0001209191-20-032317","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120032317/doc4.xml","form_type":"4"}},{"id":3133818,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-05-27T20:34:49.000Z","date":"2020-05-22","kind":"sale","acquired":false,"shares":13384,"price":70.01,"value":937013.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.115, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":784623,"source":{"system":"sec-edgar","filing":"0001209191-20-032317","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120032317/doc4.xml","form_type":"4"}},{"id":3139240,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2020-05-21T20:37:07.000Z","date":"2020-05-19","kind":"sale","acquired":false,"shares":50000,"price":65,"value":3250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":798007,"source":{"system":"sec-edgar","filing":"0001209191-20-031299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120031299/doc4.xml","form_type":"4"}},{"id":3363077,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-21T21:09:33.000Z","date":"2019-11-19","kind":"exercise","acquired":false,"shares":33618,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"270,000 options to purchase common shares were granted on June 15, 2017 and originally vested in 48 equal monthly installments commencing upon the grant date. Pursuant to Dr. Novak's amended and restated employment agreement with the Company, subject to his continued employment, beginning November 30, 2018, the remaining unvested options from this grant vest in equal monthly installments at the rate of 50% of the amounts originally scheduled to vest on any one vesting date, and the original vesting schedule was extended to reflect the amended schedule."}],"balance_after":236382,"derivative":{"exercise_price":14.43,"expiration_date":"2024-01-15","underlying":"Common Shares","underlying_shares":33618},"source":{"system":"sec-edgar","filing":"0001209191-19-057604","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919119057604/doc4.xml","form_type":"4"}},{"id":3363076,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2019-11-21T21:09:33.000Z","date":"2019-11-19","kind":"sale","acquired":false,"shares":33618,"price":70,"value":2353260.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-057604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919119057604/doc4.xml","form_type":"4"}},{"id":3363075,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2019-11-21T21:09:33.000Z","date":"2019-11-19","kind":"exercise","acquired":true,"shares":33618,"price":14.43,"value":485107.74,"ownership":{"direct":true},"balance_after":33618,"source":{"system":"sec-edgar","filing":"0001209191-19-057604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919119057604/doc4.xml","form_type":"4"}},{"id":3462527,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2019-07-12T20:10:23.000Z","date":"2019-07-10","kind":"sale","acquired":false,"shares":50000,"price":50.0013,"value":2500065.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":848007,"source":{"system":"sec-edgar","filing":"0000899243-19-019531","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924319019531/doc4.xml","form_type":"4"}},{"id":3492792,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2019-06-12T20:16:39.000Z","date":"2019-06-10","kind":"sale","acquired":false,"shares":50000,"price":45,"value":2250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":898007,"source":{"system":"sec-edgar","filing":"0000899243-19-016636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924319016636/doc4.xml","form_type":"4"}},{"id":3612957,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2019-03-05T22:59:55.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":3500,"price":42.03,"value":147105.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":948007,"source":{"system":"sec-edgar","filing":"0000899243-19-006186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924319006186/doc4.xml","form_type":"4"}},{"id":3612956,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2019-03-05T22:59:55.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":8912,"price":41.2869,"value":367948.8528,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":951507,"source":{"system":"sec-edgar","filing":"0000899243-19-006186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924319006186/doc4.xml","form_type":"4"}},{"id":3612955,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2019-03-05T22:59:55.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":64115,"price":40.2431,"value":2580186.3565,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":960419,"source":{"system":"sec-edgar","filing":"0000899243-19-006186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924319006186/doc4.xml","form_type":"4"}},{"id":3612954,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2019-03-05T22:59:55.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":8693,"price":40.0088,"value":347796.4984,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1024534,"source":{"system":"sec-edgar","filing":"0000899243-19-006186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924319006186/doc4.xml","form_type":"4"}},{"id":3629160,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2019-02-27T21:10:59.000Z","date":"2019-02-25","kind":"sale","acquired":false,"shares":14780,"price":40.0022,"value":591232.516,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.025, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1033227,"source":{"system":"sec-edgar","filing":"0000899243-19-005001","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924319005001/doc4.xml","form_type":"4"}},{"id":3698195,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2019-01-10T21:09:30.000Z","date":"2019-01-09","kind":"sale","acquired":false,"shares":82690,"price":35.01,"value":2894976.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.105, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1048007,"source":{"system":"sec-edgar","filing":"0000899243-19-000956","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924319000956/doc4.xml","form_type":"4"}},{"id":3698194,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2019-01-10T21:09:30.000Z","date":"2019-01-08","kind":"sale","acquired":false,"shares":17310,"price":35.09,"value":607407.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.24, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1130697,"source":{"system":"sec-edgar","filing":"0000899243-19-000956","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924319000956/doc4.xml","form_type":"4"}},{"id":3924096,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-21T20:54:42.000Z","date":"2018-05-17","kind":"exercise","acquired":false,"shares":39760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on October 18, 2016 with respect to 200,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning October 31, 2016."}],"balance_after":160240,"derivative":{"exercise_price":14,"expiration_date":"2016-10-18","underlying":"Common Stock","underlying_shares":39760},"source":{"system":"sec-edgar","filing":"0000899243-18-013577","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924318013577/doc4.xml","form_type":"4"}},{"id":3924095,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-21T20:54:42.000Z","date":"2018-05-17","kind":"exercise","acquired":false,"shares":35240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on September 10, 2015 with respect to 268,093 Common Shares with 94,950 shares immediately vested on the grant date and the remaining 173,143 shares vest in 31equal monthly installments thereafter."}],"balance_after":5586,"derivative":{"exercise_price":1.81,"expiration_date":"2025-09-10","underlying":"Common Stock","underlying_shares":35240},"source":{"system":"sec-edgar","filing":"0000899243-18-013577","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924318013577/doc4.xml","form_type":"4"}},{"id":3924094,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2018-05-21T20:54:42.000Z","date":"2018-05-17","kind":"sale","acquired":false,"shares":75000,"price":60,"value":4500000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1148007,"source":{"system":"sec-edgar","filing":"0000899243-18-013577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924318013577/doc4.xml","form_type":"4"}},{"id":3924093,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2018-05-21T20:54:42.000Z","date":"2018-05-17","kind":"exercise","acquired":true,"shares":39760,"price":14,"value":556640.0,"ownership":{"direct":true},"balance_after":1223007,"source":{"system":"sec-edgar","filing":"0000899243-18-013577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924318013577/doc4.xml","form_type":"4"}},{"id":3924092,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Shares","published_at":"2018-05-21T20:54:42.000Z","date":"2018-05-17","kind":"exercise","acquired":true,"shares":35240,"price":1.81,"value":63784.4,"ownership":{"direct":true},"balance_after":1183247,"source":{"system":"sec-edgar","filing":"0000899243-18-013577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924318013577/doc4.xml","form_type":"4"}},{"id":4217975,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-09-05T22:33:45.000Z","date":"2017-09-05","kind":"exercise","acquired":false,"shares":3853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on September 10, 2015 with respect to 268,093 Common Shares with 94,950 shares immediately vested on the grant date and the remaining 173,143 shares vest in 31 equal monthly installments thereafter."}],"balance_after":40826,"derivative":{"exercise_price":1.81,"expiration_date":"2025-09-10","underlying":"Common Shares","underlying_shares":3853},"source":{"system":"sec-edgar","filing":"0000899243-17-021477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317021477/doc4.xml","form_type":"4"}},{"id":4217974,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-09-05T22:33:45.000Z","date":"2017-09-05","kind":"sale","acquired":false,"shares":3853,"price":20.3271,"value":78320.3163,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.01 to $20.60, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":1148007,"source":{"system":"sec-edgar","filing":"0000899243-17-021477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317021477/doc4.xml","form_type":"4"}},{"id":4217973,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-09-05T22:33:45.000Z","date":"2017-09-05","kind":"exercise","acquired":true,"shares":3853,"price":1.81,"value":6973.93,"ownership":{"direct":true},"balance_after":1151860,"source":{"system":"sec-edgar","filing":"0000899243-17-021477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317021477/doc4.xml","form_type":"4"}},{"id":4217972,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-09-05T22:33:45.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":14617,"price":20.8711,"value":305072.8687,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.46 to $21.26, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":1148007,"source":{"system":"sec-edgar","filing":"0000899243-17-021477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317021477/doc4.xml","form_type":"4"}},{"id":4221597,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-08-30T22:36:13.000Z","date":"2017-08-30","kind":"exercise","acquired":false,"shares":5722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on September 10, 2015 with respect to 268,093 Common Shares with 94,950 shares immediately vested on the grant date and the remaining 173,143 shares vest in 31 equal monthly installments thereafter."}],"balance_after":44679,"derivative":{"exercise_price":1.81,"expiration_date":"2025-09-10","underlying":"Common Shares","underlying_shares":5722},"source":{"system":"sec-edgar","filing":"0000899243-17-021281","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317021281/doc4.xml","form_type":"4"}},{"id":4221596,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-08-30T22:36:13.000Z","date":"2017-08-28","kind":"exercise","acquired":false,"shares":17692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on September 10, 2015 with respect to 268,093 Common Shares with 94,950 shares immediately vested on the grant date and the remaining 173,143 shares vest in 31 equal monthly installments thereafter."}],"balance_after":50401,"derivative":{"exercise_price":1.81,"expiration_date":"2025-09-10","underlying":"Common Shares","underlying_shares":17692},"source":{"system":"sec-edgar","filing":"0000899243-17-021281","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317021281/doc4.xml","form_type":"4"}},{"id":4221595,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-08-30T22:36:13.000Z","date":"2017-08-30","kind":"sale","acquired":false,"shares":58103,"price":20.3079,"value":1179949.9137,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.88, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":1162624,"source":{"system":"sec-edgar","filing":"0000899243-17-021281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317021281/doc4.xml","form_type":"4"}},{"id":4221594,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-08-30T22:36:13.000Z","date":"2017-08-30","kind":"exercise","acquired":true,"shares":5722,"price":1.81,"value":10356.82,"ownership":{"direct":true},"balance_after":1220727,"source":{"system":"sec-edgar","filing":"0000899243-17-021281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317021281/doc4.xml","form_type":"4"}},{"id":4221593,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-08-30T22:36:13.000Z","date":"2017-08-28","kind":"sale","acquired":false,"shares":17692,"price":20.061,"value":354919.212,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.88, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":1215005,"source":{"system":"sec-edgar","filing":"0000899243-17-021281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317021281/doc4.xml","form_type":"4"}},{"id":4221592,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-08-30T22:36:13.000Z","date":"2017-08-28","kind":"exercise","acquired":true,"shares":17692,"price":1.81,"value":32022.52,"ownership":{"direct":true},"balance_after":1232697,"source":{"system":"sec-edgar","filing":"0000899243-17-021281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317021281/doc4.xml","form_type":"4"}},{"id":4273573,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-06-23T20:20:37.000Z","date":"2017-06-22","kind":"exercise","acquired":false,"shares":10825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on September 10, 2015 with respect to 268,093 Common Shares with 94,950 shares immediately vested on the grant date and the remaining 173,143 shares vest in 31 equal monthly installments thereafter."}],"balance_after":68093,"derivative":{"exercise_price":1.81,"expiration_date":"2025-09-10","underlying":"Common Shares","underlying_shares":10825},"source":{"system":"sec-edgar","filing":"0000899243-17-017094","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317017094/doc4.xml","form_type":"4"}},{"id":4273572,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-06-23T20:20:37.000Z","date":"2017-06-22","kind":"sale","acquired":false,"shares":10825,"price":15.3707,"value":166387.8275,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.01 to $15.59, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":1215005,"source":{"system":"sec-edgar","filing":"0000899243-17-017094","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317017094/doc4.xml","form_type":"4"}},{"id":4273571,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-06-23T20:20:37.000Z","date":"2017-06-22","kind":"exercise","acquired":true,"shares":10825,"price":1.81,"value":19593.25,"ownership":{"direct":true},"balance_after":1225830,"source":{"system":"sec-edgar","filing":"0000899243-17-017094","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317017094/doc4.xml","form_type":"4"}},{"id":4275336,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-06-21T21:42:45.000Z","date":"2017-06-21","kind":"exercise","acquired":false,"shares":11578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on September 10, 2015 with respect to 268,093 Common Shares with 94,950 shares immediately vested on the grant date and the remaining 173,143 shares vest in 31 equal monthly installments thereafter."}],"balance_after":78918,"derivative":{"exercise_price":1.81,"expiration_date":"2025-09-10","underlying":"Common Shares","underlying_shares":11578},"source":{"system":"sec-edgar","filing":"0000899243-17-016873","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317016873/doc4.xml","form_type":"4"}},{"id":4275335,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-06-21T21:42:45.000Z","date":"2017-06-20","kind":"exercise","acquired":false,"shares":3252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on September 10, 2015 with respect to 268,093 Common Shares with 94,950 shares immediately vested on the grant date and the remaining 173,143 shares vest in 31 equal monthly installments thereafter."}],"balance_after":90496,"derivative":{"exercise_price":1.81,"expiration_date":"2025-09-10","underlying":"Common Shares","underlying_shares":3252},"source":{"system":"sec-edgar","filing":"0000899243-17-016873","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317016873/doc4.xml","form_type":"4"}},{"id":4275334,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-06-21T21:42:45.000Z","date":"2017-06-19","kind":"exercise","acquired":false,"shares":15392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on September 10, 2015 with respect to 268,093 Common Shares with 94,950 shares immediately vested on the grant date and the remaining 173,143 shares vest in 31 equal monthly installments thereafter."}],"balance_after":93748,"derivative":{"exercise_price":1.81,"expiration_date":"2025-09-10","underlying":"Common Shares","underlying_shares":15392},"source":{"system":"sec-edgar","filing":"0000899243-17-016873","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317016873/doc4.xml","form_type":"4"}},{"id":4275333,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-06-21T21:42:45.000Z","date":"2017-06-21","kind":"sale","acquired":false,"shares":11578,"price":15.0152,"value":173845.9856,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.11, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":1215005,"source":{"system":"sec-edgar","filing":"0000899243-17-016873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317016873/doc4.xml","form_type":"4"}},{"id":4275332,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-06-21T21:42:45.000Z","date":"2017-06-21","kind":"exercise","acquired":true,"shares":11578,"price":1.81,"value":20956.18,"ownership":{"direct":true},"balance_after":1266583,"source":{"system":"sec-edgar","filing":"0000899243-17-016873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317016873/doc4.xml","form_type":"4"}},{"id":4275331,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-06-21T21:42:45.000Z","date":"2017-06-20","kind":"sale","acquired":false,"shares":3252,"price":15.0015,"value":48784.878,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.01, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":1215005,"source":{"system":"sec-edgar","filing":"0000899243-17-016873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317016873/doc4.xml","form_type":"4"}},{"id":4275330,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-06-21T21:42:45.000Z","date":"2017-06-20","kind":"exercise","acquired":true,"shares":3252,"price":1.81,"value":5886.12,"ownership":{"direct":true},"balance_after":1218257,"source":{"system":"sec-edgar","filing":"0000899243-17-016873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317016873/doc4.xml","form_type":"4"}},{"id":4275329,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-06-21T21:42:45.000Z","date":"2017-06-19","kind":"sale","acquired":false,"shares":15392,"price":15,"value":230880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.12, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":1215005,"source":{"system":"sec-edgar","filing":"0000899243-17-016873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317016873/doc4.xml","form_type":"4"}},{"id":4275328,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-06-21T21:42:45.000Z","date":"2017-06-19","kind":"exercise","acquired":true,"shares":15392,"price":1.81,"value":27859.52,"ownership":{"direct":true},"balance_after":1230397,"source":{"system":"sec-edgar","filing":"0000899243-17-016873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317016873/doc4.xml","form_type":"4"}},{"id":4277519,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-06-19T20:05:46.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 15, 2017 with respect to 270,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning July 15, 2017."}],"balance_after":270000,"derivative":{"exercise_price":14.43,"expiration_date":"2027-06-15","underlying":"Common Shares","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0000899243-17-016674","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317016674/doc4.xml","form_type":"4"}},{"id":4285703,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-06-12T21:02:12.000Z","date":"2017-06-09","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on September 10, 2015 with respect to 268,093 Common Shares with 94,950 shares immediately vested on the grant date and the remaining 173,143 shares vest in 31 equal monthly installments thereafter."}],"balance_after":109140,"derivative":{"exercise_price":1.81,"expiration_date":"2025-09-10","underlying":"Common Shares","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0000899243-17-016100","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317016100/doc4.xml","form_type":"4"}},{"id":4285702,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-06-12T21:02:12.000Z","date":"2017-06-08","kind":"exercise","acquired":false,"shares":4203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on September 10, 2015 with respect to 268,093 Common Shares with 94,950 shares immediately vested on the grant date and the remaining 173,143 shares vest in 31 equal monthly installments thereafter."}],"balance_after":110240,"derivative":{"exercise_price":1.81,"expiration_date":"2025-09-10","underlying":"Common Shares","underlying_shares":4203},"source":{"system":"sec-edgar","filing":"0000899243-17-016100","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317016100/doc4.xml","form_type":"4"}},{"id":4285701,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-06-12T21:02:12.000Z","date":"2017-06-09","kind":"sale","acquired":false,"shares":1100,"price":15.0755,"value":16583.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.13, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":1215005,"source":{"system":"sec-edgar","filing":"0000899243-17-016100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317016100/doc4.xml","form_type":"4"}},{"id":4285700,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-06-12T21:02:12.000Z","date":"2017-06-09","kind":"exercise","acquired":true,"shares":1100,"price":1.81,"value":1991.0,"ownership":{"direct":true},"balance_after":1216105,"source":{"system":"sec-edgar","filing":"0000899243-17-016100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317016100/doc4.xml","form_type":"4"}},{"id":4285699,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-06-12T21:02:12.000Z","date":"2017-06-08","kind":"sale","acquired":false,"shares":4203,"price":15,"value":63045.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1215005,"source":{"system":"sec-edgar","filing":"0000899243-17-016100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317016100/doc4.xml","form_type":"4"}},{"id":4285698,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-06-12T21:02:12.000Z","date":"2017-06-08","kind":"exercise","acquired":true,"shares":4203,"price":1.81,"value":7607.43,"ownership":{"direct":true},"balance_after":1219208,"source":{"system":"sec-edgar","filing":"0000899243-17-016100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317016100/doc4.xml","form_type":"4"}},{"id":4298227,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-06-01T21:25:02.000Z","date":"2017-05-30","kind":"exercise","acquired":false,"shares":3650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on September 10, 2015 with respect to 268,093 Common Shares with 94,950 share immediately vested on the grant date and the remaining 173,143 shares vest in 31 equal monthly installments thereafter."}],"balance_after":114443,"derivative":{"exercise_price":1.81,"expiration_date":"2025-09-10","underlying":"Common Shares","underlying_shares":3650},"source":{"system":"sec-edgar","filing":"0000899243-17-015008","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317015008/doc4.xml","form_type":"4"}},{"id":4298226,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-06-01T21:25:02.000Z","date":"2017-05-30","kind":"sale","acquired":false,"shares":3650,"price":15.0216,"value":54828.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.04, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":1215005,"source":{"system":"sec-edgar","filing":"0000899243-17-015008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317015008/doc4.xml","form_type":"4"}},{"id":4298225,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-06-01T21:25:02.000Z","date":"2017-05-30","kind":"exercise","acquired":true,"shares":3650,"price":1.81,"value":6606.5,"ownership":{"direct":true},"balance_after":1218655,"source":{"system":"sec-edgar","filing":"0000899243-17-015008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317015008/doc4.xml","form_type":"4"}},{"id":4313703,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-05-18T22:43:49.000Z","date":"2017-05-17","kind":"exercise","acquired":false,"shares":25923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on September 10, 2015 with respect to 268,093 Common Shares with 94,950 share immediately vested on the grant date and the remaining 173,143 shares vest in 31 equal monthly installments thereafter."}],"balance_after":118093,"derivative":{"exercise_price":1.81,"expiration_date":"2025-09-10","underlying":"Common Shares","underlying_shares":25923},"source":{"system":"sec-edgar","filing":"0000899243-17-013806","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317013806/doc4.xml","form_type":"4"}},{"id":4313702,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-05-18T22:43:49.000Z","date":"2017-05-16","kind":"exercise","acquired":false,"shares":24077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on September 10, 2015 with respect to 268,093 Common Shares with 94,950 share immediately vested on the grant date and the remaining 173,143 shares vest in 31 equal monthly installments thereafter."}],"balance_after":144016,"derivative":{"exercise_price":1.81,"expiration_date":"2025-09-10","underlying":"Common Shares","underlying_shares":24077},"source":{"system":"sec-edgar","filing":"0000899243-17-013806","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317013806/doc4.xml","form_type":"4"}},{"id":4313701,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-05-18T22:43:49.000Z","date":"2017-05-17","kind":"sale","acquired":false,"shares":25923,"price":16.0312,"value":415576.7976,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.59 to $16.56, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":1215005,"source":{"system":"sec-edgar","filing":"0000899243-17-013806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317013806/doc4.xml","form_type":"4"}},{"id":4313700,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-05-18T22:43:49.000Z","date":"2017-05-17","kind":"exercise","acquired":true,"shares":25923,"price":1.81,"value":46920.63,"ownership":{"direct":true},"balance_after":1240928,"source":{"system":"sec-edgar","filing":"0000899243-17-013806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317013806/doc4.xml","form_type":"4"}},{"id":4313699,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-05-18T22:43:49.000Z","date":"2017-05-16","kind":"sale","acquired":false,"shares":24077,"price":16.5005,"value":397282.5385,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.29 to $17.10, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":1215005,"source":{"system":"sec-edgar","filing":"0000899243-17-013806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317013806/doc4.xml","form_type":"4"}},{"id":4313698,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-05-18T22:43:49.000Z","date":"2017-05-16","kind":"exercise","acquired":true,"shares":24077,"price":1.81,"value":43579.37,"ownership":{"direct":true},"balance_after":1239082,"source":{"system":"sec-edgar","filing":"0000899243-17-013806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317013806/doc4.xml","form_type":"4"}},{"id":4328386,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-05-09T21:28:09.000Z","date":"2017-05-05","kind":"exercise","acquired":false,"shares":616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on September 10, 2015 with respect to 268,093 Common Shares with 94,950 share immediately vested on the grant date and the remaining 173,143 shares vest in 31 equal monthly installments thereafter."}],"balance_after":168093,"derivative":{"exercise_price":1.81,"expiration_date":"2025-09-10","underlying":"Common Shares","underlying_shares":616},"source":{"system":"sec-edgar","filing":"0000899243-17-012492","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317012492/doc4.xml","form_type":"4"}},{"id":4328385,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-05-09T21:28:09.000Z","date":"2017-05-05","kind":"sale","acquired":false,"shares":616,"price":16.9248,"value":10425.6768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.76 to $17.00, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":1215005,"source":{"system":"sec-edgar","filing":"0000899243-17-012492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317012492/doc4.xml","form_type":"4"}},{"id":4328384,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2017-05-09T21:28:09.000Z","date":"2017-05-05","kind":"exercise","acquired":true,"shares":616,"price":1.81,"value":1114.96,"ownership":{"direct":true},"balance_after":1215621,"source":{"system":"sec-edgar","filing":"0000899243-17-012492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317012492/doc4.xml","form_type":"4"}},{"id":4333405,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-05-04T21:44:05.000Z","date":"2017-05-04","kind":"exercise","acquired":false,"shares":13191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on September 10, 2015 with respect to 268,093 Common Shares with 94,950 share immediately vested on the grant date and the remaining 173,143 shares vest in 31 equal monthly installments thereafter."}],"balance_after":168709,"derivative":{"exercise_price":1.81,"expiration_date":"2025-09-10","underlying":"Common Shares","underlying_shares":13191},"source":{"system":"sec-edgar","filing":"0000899243-17-011883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317011883/doc4.xml","form_type":"4"}},{"id":4333404,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":137684,"kind":"person","name":"Novak Rodger","position":1,"cik":"0001682017","reported_name":"Novak Rodger","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-05-04T21:44:05.000Z","date":"2017-05-03","kind":"exercise","acquired":false,"shares":20269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on September 10, 2015 with respect to 268,093 Common Shares with 94,950 share immediately vested on the grant date and the remaining 173,143 shares vest in 31 equal monthly installments thereafter."}],"balance_after":181900,"derivative":{"exercise_price":1.81,"expiration_date":"2025-09-10","underlying":"Common Shares","underlying_shares":20269},"source":{"system":"sec-edgar","filing":"0000899243-17-011883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317011883/doc4.xml","form_type":"4"}}],"next_cursor":"2017-05-04T21:44:05.000000Z,4333404"}